ITMCTR2200006549招募中未知
A controlled clinical study to evaluate the efficacy of Tibetan medicine in the prevention and treatment of asymptomatic COVID-19 infection and mild COVID-19 patients
Tibetan Hospital Mentsee Khang of Tibet Autonomous Region0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 16 至 70（—）
- 性别
- All
入选标准
- •1. Meet the novel coronavirus diagnostic criteria for asymptomatic infection
- •Tibetan Medicine Diagnosis and Treatment Plan for COVID-19 in Tibet Autonomous Region (trial version 3).
- •The COVID-19 nucleic acid test was positive. No clinical manifestations or imaging manifestations of pneumonia.
- •2. Meet the novel coronavirus diagnostic criteria for mild coronavirus;
- •Mild cases may present with fever, dry cough, headache, sore throat, etc. The clinical symptoms were mild, and imaging showed no signs of pneumonia.
- •2.1 General Inspection
- •In the early stage of the disease, the total number of peripheral blood white blood cells is normal or decreased, and the lymphocyte count is decreased. Some patients may have increased liver enzymes, lactate dehydrogenase, muscle enzymes, myoglobin, troponin and ferritin. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were elevated in most patients, while procalcitonin (PCT) was normal. In severe and critical patients, D-dimer increased, peripheral blood lymphocytes decreased progressively, and inflammatory factors increased.
- •2.2 Etiological and serological examination
- •2.2.1 Pathogenic examination: Test novel coronavirus nucleic acid on nose and oropharyngeal swabs, sputum and other lower respiratory tract secretions, and feces by nucleic acid amplification test. Nucleic acid detection will be affected by the course of disease, specimen collection, detection process, detection reagents and other factors. In order to improve the accuracy of detection, the collection of specimens should be standardized, and specimens should be submitted to test as soon as possible after collection.
- •2.2.2 Serological examination: novel coronavirus specific IgM and IgG antibodies are positive, and the positive rate within 1 week after onset is low.
- •2.3 Chest Imaging
- •In the early stage, multiple small patches and interstitial changes were observed, especially in the outer lung zone. Further, it develops into multiple ground-glass shadows and infiltrating shadows in both lungs. In severe cases, lung consolidation may occur, and pleural effusion is rare. At MIS-C, cardiac shadow enlargement and pulmonary edema can be seen in patients with cardiac dysfunction.
- •3. It meets the development stage standards of immature fever and mature fever of Tibetan medical diseases;
- •Tibetan Medicine Diagnosis and Treatment Plan for COVID-19 in Tibet Autonomous Region (trial version 4).
- •3.1 Symptoms of disease
- •Immature heat stage: manifested as headache, fatigue, limb pain, frequent yawn, body shivering, dream, chills, fever, deafness of both ears, like sun exposure, bitter mouth, do not think about food, malaise, especially the first night pain. The pulse is fine and sometimes shaken, and the urine is cloudy.
- •Ripe heat stage: fever, fatigue, sweating, red eyes, yellow and greasy tongue coating, headache, polydipsia, wandering consciousness, etc. Pulse fine tight and number, red and yellow urine color, strong taste gas.
- •Cold and hot junction period: lumbar acid bone pain, sweating less sleep, dizziness, tinnitus, red and dry tongue rough, frequent empty vomiting, delirium, occasional body trembling, body surface fever. Pulse virtual and number, urine red clear, foam.
- •3.2 Specific symptoms
- •When the disease invaded the lungs, it was manifested as chest, ribs and back pain, shortness of breath, cough, red and yellow phlegm, smell and other symptoms. The main manifestations were
排除标准
- •1. Patients with serious diseases of heart, brain, liver, kidney and hematopoietic system;
- •2. Allergic constitution or allergic to a variety of drugs.
研究者
相似试验
尚未招募
2 期
Avabahuka management through ayurvedaCTRI/2024/03/063989Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
尚未招募
3 期
A comparitive clinical study of povidine ointment and Vranaropani malahara on fresh woundCTRI/2024/07/069772Dr Surender Redhu
已完成
2 期
management of plantar fasciitis by ayurvedic kwath iontophoresisCTRI/2021/05/033429All India Institute of Ayurveda25
尚未招募
3 期
To study the effect of Jatyadighrita suppository and Diclofenac suppository in managing the pain after surgery in Anorectal disordersCTRI/2022/09/046069Dr SRINIVASA N V
尚未招募
2 期
A clinical study to evaluate the efficacy of Nirgundi taila and Nirgundi malahara in the management of Fissure-in-anoCTRI/2023/12/060815Dr Hari R